Covered recipient · General Payments record
ANNE NICOLE KOETHE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2022–2024
$558.63
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.11 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.36 | 2 |
| Amgen Inc. | $33.00 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.06 | 1 |
| PFIZER INC. | $20.75 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.19 | 1 |
| Kiniksa Pharmaceuticals International, plc | $18.47 | 1 |
| Janssen Pharmaceuticals, Inc | $18.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.63 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822420 | CMS |
| Amgen Inc. | $17.37 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822428 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.06 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117960854 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.19 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101291832 | CMS |
| Janssen Pharmaceuticals, Inc | $18.28 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078187297 | CMS |
| Kiniksa Pharmaceuticals International, plc | $18.47 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154864707 | CMS |
| Novartis Pharmaceuticals Corporation | $18.16 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087140844 | CMS |
| Novartis Pharmaceuticals Corporation | $17.20 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087140840 | CMS |
| PFIZER INC. | $20.75 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131415764 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.